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Mitral Regurgitation in Patients With Systolic Heart Failure:
More Than a Bystander
Insuﬁciencia mitral en pacientes con insuﬁciencia cardiaca sisto´lica:
ma´s que un mero espectador
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Available online 28 October 2011Limitation of exercise capacity is a hallmark of chronic
congestive heart failure (HF), varying directly with the severity
of the disease. Muscular fatigue and dyspnea on exertion are the
most common symptoms of exercise intolerance; however, their
origin is still not fully explained.1 Heart failure is a multifaceted
clinical syndrome characterized by the inability of the heart to
generate cardiac output at levels capable of meeting the metabolic
needs of the organism associated with metabolic and inﬂammato-
ry disorders and neurohormonal activation. Several studies have
shown that exercise intolerance in patients with chronic HF results
from a complex interaction between the pulmonary, cardiovascu-
lar, skeletal muscle, hematopoietic, and neurohumoral systems.
Mechanisms that could limit exercise capacity include the heart’s
inability to sufﬁciently raise cardiac output during effort, chronic
elevated systemic vascular resistance, abnormal peripheral vaso-
dilatatory capacity, and abnormal distribution of blood ﬂow with
subsequent tissue hypoperfusion, metabolic dysfunction in skele-
tal muscles, and impaired pulmonary ventilation capacity, all of
which are characteristics of HF.2,3
The measurement of respiratory gas exchange during a
maximal exercise test, used to obtain peak oxygen consumption,
is established as an objective and reproducible method for
assessing exercise capacity and prognosis in patients with HF.4
The 6-min walk test (6MWT) is a simple test that does not require
expensive equipment or advanced training for technicians. The
patient is asked to walk the longest distance possible on a walking
course (eg, a corridor), preferably at least 30 m long, in a set
interval of 6 min. Furthermore, due to its wide availability and the
safety and ease of implementation, it is being used increasingly as
an alternative to cardiopulmonary exercise testing to evaluate the
functional capacity of patients with HF. The 6MWT is considered a
submaximal exercise that mimics everyday activities and is
generally well tolerated by patients.3,5 The distance walked during
this test is a strong and independent predictor of morbidity and
mortality in patients with left ventricular (LV) dysfunction.5SEE RELATED ARTICLE:
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doi:10.1016/j.rec.2011.08.004Several studies have combined the measurement of peak
oxygen consumption with rest echocardiography evaluation and
the attempt to identify the determinants of exercise intolerance in
patients with HF.6–10 Although conventional echocardiographic
parameters like LV ejection fraction and LV volumes have been
clearly linked to morbidity and mortality, they are poorly
correlated with exercise capacity and symptoms. Many patients
with low exercise capacity and a poor prognosis have LV function
similar to less limited and less seriously ill individuals.8,10
Conversely, abnormal right ventricular function represents a
major determinant of functional capacity in these patients. Several
other echocardiographic parameters (restrictive diastolic pattern,
presence of mitral regurgitation (MR), left atrium enlargement,
extensive regional wall motion abnormalities, low LV dP/dt, LV
asynchrony, lung comets) have been shown to be associated with
poor exercise capacity in HF. Of note, little is known about the
determinants of exercise intolerance during the 6MWT in patients
with HF.
Recently, special attention has been given to the prognostic
impact of MR in patients with systolic HF.11–13 Indeed, secondary
MR is a common complication in patients with ischemic and
nonischemic cardiomyopathies occurring as a consequence of a
ventricular disease in the absence of structural abnormalities of
the mitral valve (Fig. 1). Its incidence and clinical importance are
largely underestimated, partly because physical examination is not
always sensitive to this factor. Secondary MR results from an
imbalance between tethering forces (annular dilatation, LV
dilatation, papillary muscles displacement, LV sphericity) and
closing forces (reduction of LV contractility, global LV dyssyn-
chrony, papillary muscle dyssynchrony, altered mitral systolic
annular contraction).11When present, secondary MR may exhibit a
broad range of severity and conveys a dismal prognosis. The
increased mortality risk relates not only to the presence, but also
more importantly to the severity of MR.12 Secondary MR yields to a
signiﬁcant rise in pulmonary venous, capillary, and arterial
pressures and contributes to limitation of functional capacity
through an inadequate stroke volume adaptation at exercise.14
Circulating levels of B-type natriuretic peptide (BNP), a cardiac-
derived biomarker, has emerged as an important diagnostic and
prognostic tool in congestive HF.15 The BNP level correlates with
symptoms and exercise capacity, and increases in proportion to the
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Figure 1. Example of a patient with severe secondary mitral regurgitation due to left ventricular global and regional remodeling, mitral annulus dilatation,
and signiﬁcant mitral valve deformation. ERO, effective regurgitant oriﬁce; MAD, mitral annulus diameter; R Vol, regurgitant volume.
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ascribed to its reﬂection of the magnitude of MR. Finally,
secondary MR is characteristically dynamic, with intermittent
changes in the degree of regurgitation.9,12 The dynamic compo-
nent provides additional prognostic information over resting
evaluation and unmasks a subset of patients at high risk of
morbidity and mortality.12 Although long recognized as a
prognostic factor in systolic HF, only limited data are available
about MR’s potential effect on 6MWT distance walked in patients
with HF.
In the article published in Revista Espan˜ola de Cardiologı´a, Trivi
et al. have taken on the difﬁcult task of ﬁnding echocardiographic
predictors of exercise intolerance in patients with HF and LV
systolic dysfunction.16 Their study enrolled 151 patients with
clinically stable chronic HF and LV systolic dysfunction, deﬁned as
LV ejection fraction 40%. All patients were evaluated by
conventional rest echocardiography and assessed for LV diameter,
volume, and ejection fraction; left atrial diameter and area; and
severity of MR. Conventional and tissue Doppler imaging were also
used to assess LV ﬁlling pressures, LV ﬁlling pattern, systolic
pulmonary arterial pressure, and LV pre-ejection interval. Each
patient’s functional capacity was evaluated by the 6MWT. Their
results identiﬁed moderate-to-severe MR at rest as an independent
echocardiographic predictor of low distance walked. Left atrial
area, systolic pulmonary arterial pressure, and mitral E-wave
velocity were also related to exercise capacity in these patients.Left atrial enlargement is a marker of chronic diastolic burden and
chronic volume overload induced by MR and has been related to a
worse clinical outcome.17 The correlation between left atrial size
and exercise intolerance also probably reﬂects the presence of left
atrial dysfunction and LV diastolic dysfunction as well as some
degree of dynamic MR during exercise. In this volume overload
state, the increase in left atrial size may not only serve as a
surrogate marker of chronic diastolic dysfunction and increased
LV ﬁlling pressure but may also unmask the presence of an
underlying atrial myopathic disease process.17 The failure in left
atrial function may thus contribute to a decreased ability of the LV
to ﬁll adequately and to a reduced stroke volume during exercise.
Moreover, exercise- or stress-induced geometric ventricular
changes can further increase the regurgitant oriﬁce area and
regurgitant volume, which may aggravate dyspnea and limitation
of exercise capacity.12 Surprisingly, there was no correlation
between echocardiographic parameters estimating LV ﬁlling
pressures (E/E’) and exercise capacity. However, in the setting of
secondary MR, it is well known that E/E’ ratio is less accurate for
evaluating LV end-diastolic pressures. In the multivariable model,
the authors showed that the level of systolic pulmonary arterial
pressure failed to predict limited exercise capacity. These results
are in line with our observations in patients with chronic ischemic
LV systolic dysfunction.14 In our study, the incidence of exercise-
limiting dyspnea was similar in patients with and without
signiﬁcant pulmonary hypertension at rest. On the contrary,
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moderate-to-severe pulmonary hypertension during the test. The
degree of systolic pulmonary arterial pressure at rest did not
predict the severity of systolic pulmonary arterial pressure
during exercise. The dynamic increase in MR severity during
exercise was the major determinant of exercise-induced pulmo-
nary hypertension, and thus one of the limiting factors of
exertional capacity.
In conclusion, secondary MR in patients with systolic HF
contributes to limitation of exercise capacity and therefore should
not be seen only as an epiphenomenon of dilated cardiomyopathy.
Physicians should consider the management of MR to be a
therapeutic target that could favorably affect clinical status and
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